M&A didn’t return as hoped for in 2024. The biopharma industry is heading into the J.P. Morgan Healthcare Conference next ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

GSK (GSK) stock is in focus as the company is nearing a $1B deal to acquire IDRx, a private biotech focused on a rare ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

Pharmaceutical companies are raising the price of over 250 brand drugs this year. Nearly all the price increases are under 10 ...

If the market experiences corrections, Vikas Gupta sees attractive opportunities in sectors like large-cap banking, power, housing finance, logistics, and infrastructure EPCs.

Chandigarh: The internal security wing of the Punjab Police busted 12 terror modules with the arrest of 66 terrorists after ...

The year in politics was largely defined by quotes from Donald Trump, Joe Biden, Kamala Harris, Robert F. Kennedy Jr., Tim Walz, Elon Musk, and more.

Some of the largest, most powerful companies in the United States are racing to finance President-elect Donald Trump's ...

OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK ...